Loading...

Eyup Keles

Title(s)Assistant Professor, Dean's Office
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Eyup Keles, M.D. is board certified in Pediatrics and Pediatric Critical Medicine by the American Board of Pediatrics.

    He received his medical school training at the Istanbul University in Cerrahpasa Turkey in 1999 and completed his Pediatric residency in 2005 at the Bakirkoy Maternity and Children’s Hospital in Istanbul, Turkey. Upon moving to the United States, Dr. Keles was a Clinical Research Fellow in Pediatric Critical Care at Massachusetts General Hospital, Harvard Medical School from 2008 through 2011. From 2009 to 2011 he was a clinical fellow in the Cardiac ICU at Children’s Hospital Boston, Harvard Medical School. He was also a clinical fellow in the Pediatric ICU/ACU at Shriner’s Burn Institute from 2009 to 2011. He then went on to complete a residency in Pediatrics at the University of Arizona. Dr. Keles did transnational research on traumatic brain injury during his fellowship and after completing his Pediatric residency from 2013-2014 in MGH Research Institute Neuroscience Center.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. White S, Mowrer MC, Jesudas R, Keles ES, Roberts JC. Hemophagocytic lymphohistiocytosis in a patient with hyper IgE syndrome. Pediatr Blood Cancer. 2019 Jul 01; e27894. PMID: 31259457.
      View in: PubMed
    2. Miller BF, Keles E, Tien L, Zhang J, Kaplan D, Lo EH, Whalen MJ. The pharmacokinetics and pharmacodynamics of Kollidon VA64 dissociate its protective effects from membrane resealing after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2014 Aug; 34(8):1347-53. PMID: 24824916.
      View in: PubMed
    3. Mbye LH, Keles E, Tao L, Zhang J, Chung J, Larvie M, Koppula R, Lo EH, Whalen MJ. Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2012 Mar; 32(3):515-24. PMID: 22086196.
      View in: PubMed